Federal contract award
70RWMD23C00000021
THIS CONTRACT IS FOR INDEPENDENT SERVICES TO EVALUATE, DEVELOP, AND MAINTAIN THE SUITABILITY AND EFFECTIVENESS OF CBRN TECHNOLOGIES DEVELOPED FOR DHS.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Homeland Security |
| Office | CWMD ACQ DIV |
| NAICS | 541380 — Testing Laboratories and Services |
| PSC | AJ12 — GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; APPLIED RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $10.5M |
| Current contract value | $14.5M |
| Potential contract value / ceiling | $24.7M |
| Start date | Jul 21, 2023 |
| Current end date | Sep 20, 2026 |
| Potential end date | Jul 20, 2028 |
| Latest award activity | Aug 11, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 11 of 11 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 11, 2026 | P00010 | $0 | MODIFICATION P00009 IS TO EXERCISE OPTION PERIOD 2, CLIN 2001 AND CHANGE COR TO KATRINA WRIGHT |
| Sep 10, 2025 | P00009 | $3.6M | MODIFICATION P00009 IS TO EXERCISE OPTION PERIOD 2, CLIN 2001 AND CHANGE COR TO KATRINA WRIGHT |
| Jul 18, 2025 | P00008 | $0 | MODIFICATION P00008 IS TO EXTEND THE POP FOR CLIN 1001 AND THE SUBSEQUENT OPTION CLINS, AT NO COST TO THE GOVERNMENT. |
| May 22, 2025 | P00007 | $60.0K | MODIFICATION P00006 IS TO ADD ADDITIONAL FUNDING IN THE AMOUNT OF $60,000.00 TO CLIN 1001.THIS IS A NON-COVERED CONTRACT COMPLIANT WITH SECTION 2(D) OF THE "COST EFFICIENCY INITIATIVE" EXECUTIVE ORDER. |
| Sep 4, 2024 | P00006 | $1.0M | MODIFICATION P00006 IS TO ADD ADDITIONAL FUNDING IN THE AMOUNT OF $1,020,000.00 TO CLIN 1001. |
| Jul 18, 2024 | P00005 | $2.2M | MODIFICATION P00005 IS TO EXERCISE OPTION PERIOD 1 AND ADD ADDITIONAL FUNDING IN THE AMOUNT OF $2,183,000.00 TO CLIN 1001. |
| Mar 26, 2024 | P00004 | $577.0K | P00004- ADDITIONAL FUNDING |
| Jan 31, 2024 | P00003 | $0 | P00003- UPDATE SECTION G.1 INVOICING INSTRUCTIONS. |
| Nov 30, 2023 | P00002 | $0 | P00002- UPDATE THE STATEMENT OF WORK AND DD254 WITHIN SECTION J OF THE SUBJECT CONTRACT. |
| Sep 21, 2023 | P00001 | $362.9K | INCREMENTAL FUNDING FOR INDEPENDENT SERVICES TO EVALUATE, DEVELOP, AND MAINTAIN THE SUITABILITY AND EFFECTIVENESS OF CBRN TECHNOLOGIES DEVELOPED FOR DHS. |
| Jul 20, 2023 | 0 | $2.7M | THIS CONTRACT IS FOR INDEPENDENT SERVICES TO EVALUATE, DEVELOP, AND MAINTAIN THE SUITABILITY AND EFFECTIVENESS OF CBRN TECHNOLOGIES DEVELOPED FOR DHS. |
Estimated positioning window
Jul 20, 2027 – Jan 20, 2028
45/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 45/100. Available recorded signals: 40 points.
- Contract end 2028-07-20 (627 days from calculation)
- +25 points
- 1 historical awards in this buyer and category group
- +0 points
- 11 recorded award transactions
- +10 points
- Latest award action: 2026-08-11
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +0 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.